Kaneda Y - Search Results

1

Critical roles of cold shock domain protein A as an endogenous angiogenesis inhibitor in skeletal muscle.

Saito Y, Nakagami H, Azuma N, Hirata S, Sanada F, Taniyama Y, Morishita R, Kaneda Y, Sasajima T. Saito Y, et al. Among authors: kaneda y. Antioxid Redox Signal. 2011 Oct 15;15(8):2109-20. doi: 10.1089/ars.2010.3714. Epub 2011 Jun 14. Antioxid Redox Signal. 2011. PMID: 21473684

2

Cold shock domain protein A (CSDA) overexpression inhibits tumor growth and lymph node metastasis in a mouse model of squamous cell carcinoma.

Matsumoto G, Yajima N, Saito H, Nakagami H, Omi Y, Lee U, Kaneda Y. Matsumoto G, et al. Among authors: kaneda y. Clin Exp Metastasis. 2010 Oct;27(7):539-47. doi: 10.1007/s10585-010-9343-y. Epub 2010 Jul 10. Clin Exp Metastasis. 2010. PMID: 20623179

3

Lymphedema and therapeutic lymphangiogenesis.

Saito Y, Nakagami H, Kaneda Y, Morishita R. Saito Y, et al. Among authors: kaneda y. Biomed Res Int. 2013;2013:804675. doi: 10.1155/2013/804675. Epub 2013 Oct 9. Biomed Res Int. 2013. PMID: 24222916 Free PMC article. Review.

4

Hepatocyte growth factor as potential cardiovascular therapy.

Nakagami H, Kaneda Y, Ogihara T, Morishita R. Nakagami H, et al. Among authors: kaneda y. Expert Rev Cardiovasc Ther. 2005 May;3(3):513-9. doi: 10.1586/14779072.3.3.513. Expert Rev Cardiovasc Ther. 2005. PMID: 15889978 Review.

5

Involvement of gamma-secretase in postnatal angiogenesis.

Hayashi H, Nakagami H, Takami Y, Sato N, Saito Y, Nishikawa T, Mori M, Koriyama H, Tamai K, Morishita R, Kaneda Y. Hayashi H, et al. Among authors: kaneda y. Biochem Biophys Res Commun. 2007 Nov 23;363(3):584-90. doi: 10.1016/j.bbrc.2007.09.003. Epub 2007 Sep 14. Biochem Biophys Res Commun. 2007. PMID: 17888873

6

Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.

Tomita N, Morishita R, Taniyama Y, Koike H, Aoki M, Shimizu H, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Tomita N, et al. Among authors: kaneda y. Circulation. 2003 Mar 18;107(10):1411-7. doi: 10.1161/01.cir.0000055331.41937.aa. Circulation. 2003. PMID: 12642363

7

Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells.

Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, Kikuchi Y, Saito Y, Tamai K, Ogihara T, Kaneda Y. Nakagami H, et al. Among authors: kaneda y. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2542-7. doi: 10.1161/01.ATV.0000190701.92007.6d. Epub 2005 Oct 13. Arterioscler Thromb Vasc Biol. 2005. PMID: 16224047

8

Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.

Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, Kaneda Y. Saito Y, et al. Among authors: kaneda y. Circulation. 2006 Sep 12;114(11):1177-84. doi: 10.1161/CIRCULATIONAHA.105.602953. Epub 2006 Sep 4. Circulation. 2006. PMID: 16952986

9

HVJ (hemagglutinating virus of Japan; Sendai virus)-liposome method.

Morishita R, Kaneda Y. Morishita R, et al. Among authors: kaneda y. Methods Enzymol. 2002;346:619-27. doi: 10.1016/s0076-6879(02)46081-8. Methods Enzymol. 2002. PMID: 11883095 No abstract available.

10

Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.

Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Nakagami H, et al. Among authors: kaneda y. Diabetes. 2002 Aug;51(8):2604-11. doi: 10.2337/diabetes.51.8.2604. Diabetes. 2002. PMID: 12145177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,070 results

Search Page